1. Home
  2. XLO vs MKZR Comparison

XLO vs MKZR Comparison

Compare XLO & MKZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XLO
  • MKZR
  • Stock Information
  • Founded
  • XLO 2016
  • MKZR 2012
  • Country
  • XLO United States
  • MKZR United States
  • Employees
  • XLO N/A
  • MKZR N/A
  • Industry
  • XLO Biotechnology: Pharmaceutical Preparations
  • MKZR
  • Sector
  • XLO Health Care
  • MKZR
  • Exchange
  • XLO Nasdaq
  • MKZR Nasdaq
  • Market Cap
  • XLO 42.1M
  • MKZR 56.6M
  • IPO Year
  • XLO 2021
  • MKZR N/A
  • Fundamental
  • Price
  • XLO $1.11
  • MKZR $4.20
  • Analyst Decision
  • XLO Buy
  • MKZR
  • Analyst Count
  • XLO 1
  • MKZR 0
  • Target Price
  • XLO $4.00
  • MKZR N/A
  • AVG Volume (30 Days)
  • XLO 738.6K
  • MKZR 69.1K
  • Earning Date
  • XLO 11-07-2024
  • MKZR 01-01-0001
  • Dividend Yield
  • XLO N/A
  • MKZR 3.00%
  • EPS Growth
  • XLO N/A
  • MKZR N/A
  • EPS
  • XLO N/A
  • MKZR N/A
  • Revenue
  • XLO $4,620,000.00
  • MKZR $17,563,335.00
  • Revenue This Year
  • XLO N/A
  • MKZR N/A
  • Revenue Next Year
  • XLO $368.76
  • MKZR N/A
  • P/E Ratio
  • XLO N/A
  • MKZR N/A
  • Revenue Growth
  • XLO N/A
  • MKZR N/A
  • 52 Week Low
  • XLO $0.50
  • MKZR $1.05
  • 52 Week High
  • XLO $1.93
  • MKZR $5.50
  • Technical
  • Relative Strength Index (RSI)
  • XLO 54.59
  • MKZR N/A
  • Support Level
  • XLO $0.84
  • MKZR N/A
  • Resistance Level
  • XLO $1.28
  • MKZR N/A
  • Average True Range (ATR)
  • XLO 0.13
  • MKZR 0.00
  • MACD
  • XLO 0.01
  • MKZR 0.00
  • Stochastic Oscillator
  • XLO 62.72
  • MKZR 0.00

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

About MKZR MacKenzie Realty Capital Inc.

Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.

Share on Social Networks: